Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)

Vollenweider, F.X, Leenders, K.L, Scharfetter, C, Antonini, A, Maguire, P, Missimer, J, Angst, J · 1997 · European Neuropsychopharmacology

Abstract

To date, the ketamine/PCP model of psychosis has been proposed to be one of the best pharmacological models to mimic schizophrenic psychosis in healthy volunteers, since ketamine can induce both positive and negative symptoms of schizophrenia. At subanesthetic doses, ketamine has been reported to primarily block N-methyl-D-aspartate (NMDA) receptor complex giving support to a glutamate deficiency hypothesis in schizophrenia. Positron emission tomography was used to study ketamine-induced psychotic symptom formation in relation to cerebral metabolic alterations in healthy volunteers. Our study shows that NMDA receptor blockade results in a hyperfrontal metabolic pattern. Increased metabolic activity in the frontomedial and anterior cingulate cortex correlated positively with psychotic symptom formation, in particular with ego pathology. Analysis of correlations between syndrome scores and metabolic rate of glucose (CMRglu) or metabolic gradients (ratios) revealed that each psychopathological syndrome was associated with a number of metabolic alterations in cortical and subcortical brain regions, suggesting that not a single brain region, but distributed neuronal networks are involved in acute psychotic symptom formation.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0924-977x(96)00039-9

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 94 · Cited by 353

Research works printed but not linked: 4

  1. Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie AMDP (1981) Das AMDP-System. Manual zur Dokumentation psychiatrischer Befunde. Springer-Verlag, Berlin.
  2. Dittrich, A. (1994) Psychological aspects of altered states of consciousness of the LSD type: measurements of their basic dimensions and prediction of individual differences. In: Pletscher, A. and Ladewig, D. (Eds.), 50 years of LSD. Current Status and Perspectives of Hallucinogens. Parthenon Publishing, New York, pp. 101–118.
  3. Scharfetter, C. and Weber, A.C. (1985) Ich-Psychopathologie. Multivariate Datenanalyse zu einem phänomenologischen Konzept. In: von Pflug, B., Foerster, K. and Straube, E. (Eds.), Perspektiven der Schizophrenie-Forschung. Fischer, Stuttgart–New York, pp. 15–23.
  4. Troupin, A.S., Mendius, J.R., Cheng, F. and Risinger, M.W. (1986) MK-801. In: Meldrum, B.S. and Porter, R.J. (Eds.), Epilepsy. John Libbey and Company Ltd, London, pp. 191–201.

Metadata

Authors
Vollenweider, F. X., Leenders, K. L., Scharfetter, C., Antonini, A., Maguire, P., Missimer, J., & Angst, J.
Affiliations
  • University Hospital Zurich (CH)
  • Paul Scherrer Institute (CH)
Corresponding author
Vollenweider, F.X
Venue
European Neuropsychopharmacology
Publisher
Elsevier BV
Published
1997-02
Volume
7
Issue
1
Pages
9-24
ISSN
0924-977X (ISSN-L)
OpenAlex
W2133462240
Cited by
353
References
94
Citations by year
2026: 3 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 12 · 2020: 13 · 2019: 12 · 2018: 15 · 2017: 15 · 2016: 13 · 2015: 20 · 2014: 16 · 2013: 15 · 2012: 15
FWCI
8.07
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • European Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
  • DORA PSI (Paul Scherrer Institute) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Keywords
ketamine, psychosis model, schizophrenia, NMDA receptor blockade, brain glucose metabolism, anterior cingulate cortex, positive and negative symptoms, metabolic gradients, neuronal networks
MeSH terms
Adult, Brain Chemistry, Deoxyglucose, Female, Fluorine Radioisotopes, Frontal Lobe, Glucose, Humans, Ketamine, Functional Laterality, Male, Psychometrics, Psychoses, Substance-Induced, Surveys and Questionnaires, Tomography, Emission-Computed, Excitatory Amino Acid Antagonists, Fluorodeoxyglucose F18

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). https://app.cochat.ai/papers/10.1016/s0924-977x(96)00039-9
The paper
Vollenweider, F. X., Leenders, K. L., Scharfetter, C., Antonini, A., Maguire, P., Missimer, J., & Angst, J. (1997). Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). European Neuropsychopharmacology. https://doi.org/10.1016/s0924-977x(96)00039-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.